ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003

NIH Alternative Medicine Office Releases RFA For Grant Awards

April 9, 1993

Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’

December 11, 1992

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

April 20, 2007

NI Communications Effort, Saves By Congress, Now A Major National Cancer Program Resource

August 15, 1975

In Brief: HEW Clamps Down On Former Employees Hired To Go After Jobs They Had Helped Develop

May 3, 1974